Use of p62/SQSTM1 antibodies for neuropathological diagnosis

Neuropathology and Applied Neurobiology

Volumn 34, Issue 2, 2008, Pages 169-180

  Kuusisto, E ^a   Kauppinen, T ^a   Alafuzoff, I ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Degenerative disease; Immunohistochemistry; Inclusion; Synuclein; Tau; TDP 43

Indexed keywords

ALPHA SYNUCLEIN; DNA BINDING PROTEIN; EPITOPE; MONOCLONAL ANTIBODY; PROTEIN P62; TAU PROTEIN;

ARTICLE; ASTROCYTE; CELL INCLUSION; COILED BODY; DEGENERATIVE DISEASE; DEMENTIA; FRONTOTEMPORAL DEMENTIA; GLIA; HUMAN; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEUROPATHOLOGY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIBODIES; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BRAIN; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; NEURODEGENERATIVE DISEASES; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS;

EID: 40149112133     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2007.00884.x     Document Type: Article

References (38)

1. Lowe J. The pathological diagnosis of neurodegenerative diseases causing dementia. Curr Top Pathol 2001 95 : 149 77
2. Dickson DW. Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases. Acta Neuropathol 2005 109 : 14 24
3. Alafuzoff I, Pikkarainen M, Al-Sarraj S, Arzberger T, Bell J, Bodi I, Bogdanovic N, Budka H, Bugiani O, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Hauw JJ, Kamphorst W, King A, Kopp N, Korkolopoulou P, Kovacs GG, Meyronet D, Parchi P, Patsouris E, Preusser M, Ravid R, Roggendorf W, Seilhean D, Streichenberger N, Thal DR, Kretzschmar H. Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol 2006 65 : 740 57
4. Lowe J, Hand N, Mayer RJ. Application of ubiquitin immunohistochemistry to the diagnosis of disease. Methods Enzymol 2005 399 : 86 119
5. Ikeda K, Akiyama H, Arai T, Nishimura T. Glial tau pathology in neurodegenerative diseases: their nature and comparison with neuronal tangles. Neurobiol Aging 1998 19 : S85 91
6. Kuusisto E, Salminen A, Alafuzoff I. Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. Neuroreport 2001 12 : 2085 90
7. Kuusisto E, Salminen A, Alafuzoff I. Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation. Neuropathol Appl Neurobiol 2002 28 : 228 37
8. Kuusisto E, Parkkinen L, Alafuzoff I. Morphogenesis of nigral inclusions: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 2003 62 : 1241 53
9. Arai T, Nonaka T, Hasegawa M, Akiyama H, Yoshida M, Hashizume Y, Tsuchiya K, Oda T, Ikeda K. Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62. Neurosci Lett 2003 342 : 41 4
10. Donaldson KM, Li W, Ching KA, Batalov S, Tsai CC, Joazeiro CA. Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates. Proc Natl Acad Sci USA 2003 100 : 8892 7
11. Nagaoka U, Kim K, Jana NR, Doi H, Maruyama M, Mitsui K, Oyama F, Nukina N. Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions. J Neurochem 2004 91 : 57 68
12. Mizuno Y, Amari M, Takatama M, Aizawa H, Mihara B, Okamoto K. Immunoreactivities of p62, an ubiqutin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis. J Neurol Sci 2006 249 : 13 18
13. Uchikado H, Li A, Lin WL, Dickson DW. Heterogeneous inclusions in neurofilament inclusion disease. Neuropathology 2006 26 : 417 21
14. Scott IS, Lowe JS. The ubiquitin-binding protein p62 identifies argyrophilic grain pathology with greater sensitivity than conventional silver stains. Acta Neuropathol 2007 113 : 417 20
15. Stumptner C, Heid H, Fuchsbichler A, Hauser H, Mischinger HJ, Zatloukal K, Denk H. Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent. Am J Pathol 1999 154 : 1701 10
16. Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L, Kleinert R, Prinz M, Aguzzi A, Denk H. p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 2002 160 : 255 63
17. Wooten MW, Hu X, Babu JR, Seibenhener ML, Geetha T, Paine MG, Wooten MC. Signaling, polyubiquitination, trafficking, and inclusions: sequestosome 1/p62's role in neurodegenerative disease. J Biomed Biotechnol 2006 2006 : 62079
18. Moscat J, Diaz-Meco MT, Wooten MW. Signal integration and diversification through the p62 scaffold protein. Trends Biochem Sci 2007 32 : 95 100
19. Sanz L, Diaz-Meco MT, Nakano H, Moscat J. The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway. EMBO J 2000 19 : 1576 86
20. Geetha T, Jiang J, Wooten MW. Lysine 63 polyubiquitination of the nerve growth factor receptor TrkA directs internalization and signaling. Mol Cell 2005 20 : 301 12
21. Shin J. P62 and the sequestosome, a novel mechanism for protein metabolism. Arch Pharm Res 1998 21 : 629 33
22. Seibenhener ML, Babu JR, Geetha T, Wong HC, Krishna NR, Wooten MW. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol 2004 24 : 8055 68
23. Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H, Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 2005 171 : 603 14
24. Gal J, Strom AL, Kilty R, Zhang F, Zhu H. p62 accumulates and enhances aggregate formation in model systems of familial amyotrophic lateral sclerosis. J Biol Chem 2007 282 : 11068 77
25. Gong J, Xu J, Bezanilla M, van Huizen R, Derin R, Li M. Differential stimulation of PKC phosphorylation of potassium channels by ZIP1 and ZIP2. Science 1999 285 : 1565 9
26. Lange S, Xiang F, Yakovenko A, Vihola A, Hackman P, Rostkova E, Kristensen J, Brandmeier B, Franzen G, Hedberg B, Gunnarsson LG, Hughes SM, Marchand S, Sejersen T, Richard I, Edstrom L, Ehler E, Udd B, Gautel M. The kinase domain of titin controls muscle gene expression and protein turnover. Science 2005 308 : 1599 603
27. Layfield R, Hocking LJ. SQSTM1 and Paget's disease of bone. Calcif Tissue Int 2004 75 : 347 57
28. Rodriguez A, Duran A, Selloum M, Champy MF, Diez-Guerra FJ, Flores JM, Serrano M, Auwerx J, Diaz-Meco MT, Moscat J. Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. 2006 3 : 211 22
29. Martin P, Diaz-Meco MT, Moscat J. The signaling adapter p62 is an important mediator of T helper 2 cell function and allergic airway inflammation. EMBO J 2006 25 : 3524 33
30. Kuusisto E. Role of the p62 Protein in the Formation of Neuropathological Cytoplasmic Inclusions. PhD Thesis. Series of Reports, no. 70. Department of Neurology, University of Kuopio (Finland), 2004 p. 94. Available at: http://www.uku.fi/neuro/theses/
31. Leong AS. Pitfalls in diagnostic immunohistology. Adv Anat Pathol 2004 11 : 86 93
32. Martikainen P, Louhelainen AM, Kauppinen T, Alafuzoff I. Human brain tissue microarrays as a platform to investigate diseases of the nervous system. Brain Res 2006 1089 : 33 43
33. Kauppinen T, Martikainen P, Alafuzoff I. Human postmortem brain tissue and 2-mm tissue microarrays. Appl Immunohistochem Mol Morphol 2006 14 : 353 9
34. Beach TG, Walker DG, Sue LI, Newell A, Adler CC, Joyce JN. Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers. J Neuropathol Exp Neurol 2004 63 : 329 37
35. Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002 61 : 935 46
36. Nakaso K, Kitayama M, Ishii T, Bannai S, Yanagawa T, Kimura K, Nakashima K, Ohama E, Yamada K. Effects of kainate-mediated excitotoxicity on the expression of rat counterparts of A170 and MSP23 stress proteins in the brain. Brain Res Mol Brain Res 1999 69 : 155 63
37. Mackenzie IR, Shi J, Shaw CL, Duplessis D, Neary D, Snowden JS, Mann DM. Dementia lacking distinctive histology (DLDH) revisited. Acta Neuropathol 2006 112 : 551 9
38. Lowe J. Establishing a pathological diagnosis in degenerative dementias. Brain Pathol 1998 8 : 403 6